Singapore markets closed
Straits Times Index
3,110.73 +36.47 (+1.19%) Nikkei
32,307.86 -550.45 (-1.68%) Hang Seng
16,334.37 -11.52 (-0.07%) FTSE 100
7,554.47 +40.75 (+0.54%) Bitcoin USD
44,118.96 +310.53 (+0.71%) CMC Crypto 200
914.81 +18.10 (+2.02%)
Eupraxia Pharmaceuticals Inc. (EPRX.TO)
Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
At close: 03:59PM EST
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 159.76M |
| Enterprise value | 141.97M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 9.37 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -4.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.43 |
| 52-week change 3 | 58.38% |
| S&P500 52-week change 3 | 15.38% |
| 52-week high 3 | 9.10 |
| 52-week low 3 | 3.27 |
| 50-day moving average 3 | 6.05 |
| 200-day moving average 3 | 6.47 |
Share statistics
| Avg vol (3-month) 3 | 23.89k |
| Avg vol (10-day) 3 | 10.01k |
| Shares outstanding 5 | 27.26M |
| Implied shares outstanding 6 | 27.26M |
| Float 8 | 21.26M |
| % held by insiders 1 | 11.17% |
| % held by institutions 1 | 18.21% |
| Shares short (29 Nov 2023) 4 | 631.14k |
| Short ratio (29 Nov 2023) 4 | 53.44 |
| Short % of float (29 Nov 2023) 4 | 4.38% |
| Short % of shares outstanding (29 Nov 2023) 4 | 2.32% |
| Shares short (prior month 30 Oct 2023) 4 | 622.07k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -57.42% |
| Return on equity (ttm) | -199.77% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -30.11M |
| Net income avi to common (ttm) | -33.35M |
| Diluted EPS (ttm) | -1.53 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 33.21M |
| Total cash per share (mrq) | 1.22 |
| Total debt (mrq) | 15.41M |
| Total debt/equity (mrq) | 102.34% |
| Current ratio (mrq) | 1.75 |
| Book value per share (mrq) | 0.62 |
Cash flow statement
| Operating cash flow (ttm) | -25.09M |
| Levered free cash flow (ttm) | -15.41M |
© 2023 Yahoo. All rights reserved.